Zimbabwe is one of the world's first countries to roll out lenacapavir, a long-acting HIV prevention drug that is ...
HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...
By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...
A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...
Zimbabwe launches lenacapavir, a long-acting HIV prevention drug, aiming to reduce new infections among high-risk groups with ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
Groups impacted by the cuts - from the city health department to local clinics - fear the loss of funds will limit their ...
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that ...
Funds will be affected in California, Colorado, Illinois and Minnesota.
"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.